Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial

This publication has 33 references indexed in Scilit:

• Incidence of chemotherapy‐induced nausea and emesis after modern antiemetics
  Cancer, 2004
• The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers
  Annals of Oncology, 2004
• Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5‐hydroxytryptamine‐3 antiemetics
  Cancer, 2003
• Clinical Science Review: Comparative Review of 5-HT₃Receptor Antagonists in the Treatment of Acute Chemotherapy-Induced Nausea and Vomiting
  Cancer Investigation, 2000
• Dolasetron
  Drugs, 1997
• Effect of postchemotherapy nausea and vomiting on health-related quality of life
  Supportive Care in Cancer, 1997
• An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting
  European Journal Of Cancer, 1997
• Dexamethasone, Granisetron, or Both for the Prevention of Nausea and Vomiting during Chemotherapy for Cancer
  New England Journal of Medicine, 1995
• Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy
  The Lancet, 1991
• Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone.
  Journal of Clinical Oncology, 1991